Sterile Injectable Drugs Market 2027 By Applications | The Insight Partners

Sterile Injectable Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Applications (Cancer, Diabetes, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, Others)

Report Code: TIPRE00011967 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Sterile injectable drugs are sterile, parenteral preparations containing one more Active Pharmaceutical Ingredient (API) intended for administration into the body. These preparations are administered by injection, infusion, or implantation in the body with the help of a needle, syringe, or implantable devices.

MARKET DYNAMICS

The sterile injectable drugs market is driving due to the growing prevalence of chronic diseases and cancer and the increasing demand for cell therapies for the treatment of these diseases. However, the high cost of devices, stringent regulations, and lack of skilled personnel with sound technical know-how is likely to restraint the market growth during the forecast period. Moreover, the rise in government initiatives to enhance health care facilities, focus on research and increase in research funding contribute to the growth of the market for sterile injectable drugs.

MARKET SCOPE

The "Sterile Injectable Drugs Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of sterile injectable drugs market with detailed market segmentation by product, technology, application and end user. The sterile injectable drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in sterile injectable drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The sterile injectable drugs market is segmented on the basis of application. On the basis of application, the market is categorized as cancer, diabetes, cardiovascular diseases, musculoskeletal, CNS, infections and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the sterile injectable drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The sterile injectable drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting sterile injectable drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the sterile injectable drugs market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the sterile injectable drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from sterile injectable drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for sterile injectable drugs in the global market. Below mentioned is the list of few companies engaged in the sterile injectable drugs market.

The report also includes the profiles of key players in sterile injectable drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   AstraZeneca Plc.
  •   Baxter International Inc.
  •   GILEAD SCIENCES, INC.
  •   GlaxoSmithKline plc.
  •   hameln group gmbh
  •   Johnson & Johnson Services, Inc.
  •   Merck & Co., Inc.
  •   Novartis AG
  •   Pfizer Inc.
  •   Sanofi


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Sterile Injectable Drugs Market - By Applications
1.3.2 Sterile Injectable Drugs Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. STERILE INJECTABLE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. STERILE INJECTABLE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. STERILE INJECTABLE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. STERILE INJECTABLE DRUGS - GLOBAL MARKET OVERVIEW
6.2. STERILE INJECTABLE DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. STERILE INJECTABLE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
7.1. OVERVIEW
7.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
7.3. CANCER
7.3.1. Overview
7.3.2. Cancer Market Forecast and Analysis
7.4. DIABETES
7.4.1. Overview
7.4.2. Diabetes Market Forecast and Analysis
7.5. CARDIOVASCULAR DISEASES
7.5.1. Overview
7.5.2. Cardiovascular Diseases Market Forecast and Analysis
7.6. MUSCULOSKELETAL
7.6.1. Overview
7.6.2. Musculoskeletal Market Forecast and Analysis
7.7. CNS
7.7.1. Overview
7.7.2. CNS Market Forecast and Analysis
7.8. INFECTIONS
7.8.1. Overview
7.8.2. Infections Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. STERILE INJECTABLE DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Sterile Injectable Drugs Market Overview
8.1.2 North America Sterile Injectable Drugs Market Forecasts and Analysis
8.1.3 North America Sterile Injectable Drugs Market Forecasts and Analysis - By Applications
8.1.4 North America Sterile Injectable Drugs Market Forecasts and Analysis - By Countries
8.1.4.1 United States Sterile Injectable Drugs Market
8.1.4.1.1 United States Sterile Injectable Drugs Market by Applications
8.1.4.2 Canada Sterile Injectable Drugs Market
8.1.4.2.1 Canada Sterile Injectable Drugs Market by Applications
8.1.4.3 Mexico Sterile Injectable Drugs Market
8.1.4.3.1 Mexico Sterile Injectable Drugs Market by Applications
8.2. EUROPE
8.2.1 Europe Sterile Injectable Drugs Market Overview
8.2.2 Europe Sterile Injectable Drugs Market Forecasts and Analysis
8.2.3 Europe Sterile Injectable Drugs Market Forecasts and Analysis - By Applications
8.2.4 Europe Sterile Injectable Drugs Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Sterile Injectable Drugs Market
8.2.4.1.1 Germany Sterile Injectable Drugs Market by Applications
8.2.4.2 France Sterile Injectable Drugs Market
8.2.4.2.1 France Sterile Injectable Drugs Market by Applications
8.2.4.3 Italy Sterile Injectable Drugs Market
8.2.4.3.1 Italy Sterile Injectable Drugs Market by Applications
8.2.4.4 Spain Sterile Injectable Drugs Market
8.2.4.4.1 Spain Sterile Injectable Drugs Market by Applications
8.2.4.5 United Kingdom Sterile Injectable Drugs Market
8.2.4.5.1 United Kingdom Sterile Injectable Drugs Market by Applications
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Sterile Injectable Drugs Market Overview
8.3.2 Asia-Pacific Sterile Injectable Drugs Market Forecasts and Analysis
8.3.3 Asia-Pacific Sterile Injectable Drugs Market Forecasts and Analysis - By Applications
8.3.4 Asia-Pacific Sterile Injectable Drugs Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Sterile Injectable Drugs Market
8.3.4.1.1 Australia Sterile Injectable Drugs Market by Applications
8.3.4.2 China Sterile Injectable Drugs Market
8.3.4.2.1 China Sterile Injectable Drugs Market by Applications
8.3.4.3 India Sterile Injectable Drugs Market
8.3.4.3.1 India Sterile Injectable Drugs Market by Applications
8.3.4.4 Japan Sterile Injectable Drugs Market
8.3.4.4.1 Japan Sterile Injectable Drugs Market by Applications
8.3.4.5 South Korea Sterile Injectable Drugs Market
8.3.4.5.1 South Korea Sterile Injectable Drugs Market by Applications
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Sterile Injectable Drugs Market Overview
8.4.2 Middle East and Africa Sterile Injectable Drugs Market Forecasts and Analysis
8.4.3 Middle East and Africa Sterile Injectable Drugs Market Forecasts and Analysis - By Applications
8.4.4 Middle East and Africa Sterile Injectable Drugs Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Sterile Injectable Drugs Market
8.4.4.1.1 South Africa Sterile Injectable Drugs Market by Applications
8.4.4.2 Saudi Arabia Sterile Injectable Drugs Market
8.4.4.2.1 Saudi Arabia Sterile Injectable Drugs Market by Applications
8.4.4.3 U.A.E Sterile Injectable Drugs Market
8.4.4.3.1 U.A.E Sterile Injectable Drugs Market by Applications
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Sterile Injectable Drugs Market Overview
8.5.2 South and Central America Sterile Injectable Drugs Market Forecasts and Analysis
8.5.3 South and Central America Sterile Injectable Drugs Market Forecasts and Analysis - By Applications
8.5.4 South and Central America Sterile Injectable Drugs Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Sterile Injectable Drugs Market
8.5.4.1.1 Brazil Sterile Injectable Drugs Market by Applications
8.5.4.2 Argentina Sterile Injectable Drugs Market
8.5.4.2.1 Argentina Sterile Injectable Drugs Market by Applications
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL STERILE INJECTABLE DRUGS MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of the World
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. STERILE INJECTABLE DRUGS MARKET, KEY COMPANY PROFILES
11.1. ASTRAZENECA PLC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BAXTER INTERNATIONAL INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GILEAD SCIENCES, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLAXOSMITHKLINE PLC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. HAMELN GROUP GMBH
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. JOHNSON AND JOHNSON SERVICES, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERCK AND CO., INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NOVARTIS AG
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PFIZER INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SANOFI
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. AstraZeneca Plc.
2. Baxter International Inc.
3. GILEAD SCIENCES, INC.
4. GlaxoSmithKline plc.
5. hameln group gmbh
6. Johnson & Johnson Services, Inc.
7. Merck & Co., Inc.
8. Novartis AG
9. Pfizer Inc.
10. Sanofi
TIPRE00011967
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking